The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.
Swiss pharma company Roche has scored approval from the European Commission (EC) for its flu pill Xofluza. ... We are delighted that the European Commission has approved Xofluza, a first-in-class, single-dose oral medicine, for the treatment of influenza,
Another competitor in the SMA market – Roche’s Evrysdi (risdiplam) – was recently approved in the US for the treatment of SMA in adults and children aged two months and older, following ... Roche has priced Evrysdi by patient weight, with a maximum
Roche’s Actemra (tocilizumab) and Sanofi’s Kevzara (sarilumab) have been found to cut the risk of death in critically ill COVID-19 patients in a study led by Imperial College ... This includes Roche’s own phase 3 COVACTA study, in which Actemra did
According to Roche, tiragolumab is the first anti-TIGIT molecule to win a BTD from the FDA. ... outcomes for people with certain types of lung cancer,” said Levi Garraway, chief medical officer and head of Global Product Development, Roche.
The European Commission has approved a fixed dose combination of Roche’s antibody blockbusters Herceptin and Perjeta under the new brand name Phesgo. ... In Roche’s half-year report for 2020, sales of Herceptin had dropped by 28%, reflecting the
[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...